GBS (NYSE:GBS) Trading 0.9% Higher – Still a Buy?

GBS Inc. (NYSE:GBSGet Free Report) rose 0.9% on Thursday . The stock traded as high as $2.28 and last traded at $2.20. Approximately 52,371 shares changed hands during trading, a decline of 95% from the average daily volume of 955,325 shares. The stock had previously closed at $2.18.

GBS Stock Performance

The stock has a fifty day simple moving average of $1.86 and a two-hundred day simple moving average of $1.65. The stock has a market cap of $31.57 million, a price-to-earnings ratio of -3.79 and a beta of 1.32.

GBS Company Profile

(Get Free Report)

GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.

Recommended Stories

Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.